Annual EBITDA
-$204.15M$11.99M-6.24%
Summary
- Current Value
- As of today, ABCL annual EBITDA is -$204.15M, down -6.24% on
- Historical Performance
- ABCL annual EBITDA is down -185.36% over the past 3 years, and down -131608.39% over the past 5 years
- All-Time High Comparison
- ABCL annual EBITDA is currently -178.47% below its historical high of $260.17M set on
- 3-Year Low Comparison
- ABCL annual EBITDA is at its 3-year low
- Sector Comparison
- ABCL annual EBITDA is higher than 7.14% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$204.15M | -6.2% | -185.4% | -10000.0% | -10000.0% | |
| Quarterly EBITDA | -$69.04M | -24.7% | -216.0% | -8210.2% | – | |
| TTM EBITDA | -$226.48M | -4.9% | -150.9% | -6212.6% | – | |
| Price | $4.27 | +42.3% | -58.9% | -90.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $28.83M | -24.2% | -92.3% | +148.3% | +226.5% | |
| Annual EPS | -$0.55 | -9.3% | -214.8% | -3769.2% | -10000.0% | |
| Annual EBIT | -$301.15M | -35.0% | -235.7% | -10000.0% | -10000.0% | |
| Annual Net Income | -$162.86M | -11.2% | -206.1% | -7266.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $260.17M | N/A | -178.5% |
| 5Y | $260.17M | -178.5% | |
| All | $260.17M | -178.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$204.15M | at low | |
| 5Y | -$204.15M | at low | |
| All | -$204.15M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$204.15M | -6.2% | |
| -$192.16M | -173.9% | |
| $260.17M | +8.8% | |
| $239.15M | +41.0% |
| Year | Value | Change |
|---|---|---|
| $169.62M | >+9,900.0% | |
| -$155.00K | -110.8% | |
| $1.44M | - |
FAQ
What is the current annual EBITDA of ABCL?
As of today, ABCL annual EBITDA is -$204.15M
What is 1-year change in ABCL annual EBITDA?
ABCL annual EBITDA is down -6.24% year-over-year
What is 3-year change in ABCL annual EBITDA?
ABCL annual EBITDA is down -185.36% over the past 3 years
How far is ABCL annual EBITDA from its all-time high?
ABCL annual EBITDA is currently -178.47% below its historical high of $260.17M set on December 31, 2022
How does ABCL annual EBITDA rank versus sector peers?
ABCL annual EBITDA is higher than 7.14% of companies in Healthcare sector
When is ABCL next annual earnings release?
The next annual earnings release for ABCL is on
Quarterly EBITDA
-$69.04M$26.52M-62.35%
Summary
- Current Value
- As of today, ABCL quarterly EBITDA is -$69.04M, down -62.35% on
- Historical Performance
- ABCL quarterly EBITDA is down -24.69% year-over-year, and down -216.04% over the past 3 years
- All-Time High Comparison
- ABCL quarterly EBITDA is currently -125.15% below its historical high of $274.56M set on
- 3-Year Low Comparison
- ABCL quarterly EBITDA is at its 3-year low
- Sector Comparison
- ABCL quarterly EBITDA is higher than 5.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$69.04M | -62.4% | -24.7% | -216.0% | -8210.2% | |
| Annual EBITDA | -$204.15M | – | -6.2% | -185.4% | -10000.0% | |
| TTM EBITDA | -$226.48M | -6.4% | -4.9% | -150.9% | -6212.6% | |
| Price | $4.27 | -24.7% | +42.3% | -58.9% | -90.3% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $8.96M | -47.6% | +37.6% | -91.2% | -4.3% | |
| Quarterly EPS | -$0.19 | -64.3% | -10.3% | -326.7% | -992.0% | |
| Quarterly EBIT | -$76.28M | -53.8% | +18.6% | -244.6% | -4215.3% | |
| Quarterly Net Income | -$57.12M | -64.5% | -11.8% | -314.5% | -2022.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$42.53M | -62.4% | |
| 3Y | -$20.86M | N/A | -230.9% |
| 5Y | $274.56M | -125.2% | |
| All | $274.56M | -125.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$69.04M | at low | |
| 3Y | -$69.04M | at low | |
| 5Y | -$69.04M | at low | |
| All | -$69.04M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ABCL?
As of today, ABCL quarterly EBITDA is -$69.04M
What is ABCL quarterly EBITDA most recent change?
ABCL quarterly EBITDA was down -62.35% on September 30, 2025
What is 1-year change in ABCL quarterly EBITDA?
ABCL quarterly EBITDA is down -24.69% year-over-year
How far is ABCL quarterly EBITDA from its all-time high?
ABCL quarterly EBITDA is currently -125.15% below its historical high of $274.56M set on March 31, 2022
How does ABCL quarterly EBITDA rank versus sector peers?
ABCL quarterly EBITDA is higher than 5.33% of companies in Healthcare sector
When is ABCL next earnings release?
The next earnings release for ABCL is on
TTM EBITDA
-$226.48M$13.67M-6.43%
Summary
- Current Value
- As of today, ABCL TTM EBITDA is -$226.48M, down -6.43% on
- Historical Performance
- ABCL TTM EBITDA is down -4.92% year-over-year, and down -150.87% over the past 3 years
- All-Time High Comparison
- ABCL TTM EBITDA is currently -150.87% below its historical high of $445.22M set on
- 3-Year Low Comparison
- ABCL TTM EBITDA is at its 3-year low
- Sector Comparison
- ABCL TTM EBITDA is higher than 5.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$226.48M | -6.4% | -4.9% | -150.9% | -6212.6% | |
| Annual EBITDA | -$204.15M | – | -6.2% | -185.4% | -10000.0% | |
| Quarterly EBITDA | -$69.04M | -62.4% | -24.7% | -216.0% | -8210.2% | |
| Price | $4.27 | -24.7% | +42.3% | -58.9% | -90.3% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $35.32M | +7.5% | +7.2% | -94.1% | +6.7% | |
| TTM EPS | -$0.58 | -3.2% | +4.0% | -172.5% | -4747.6% | |
| TTM EBIT | -$261.28M | +6.2% | +15.2% | -161.8% | -5408.4% | |
| TTM Net Income | -$171.68M | -3.6% | +2.3% | -169.1% | -9354.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$212.80M | -6.4% | |
| 3Y | $316.05M | N/A | -171.7% |
| 5Y | $445.22M | -150.9% | |
| All | $445.22M | -150.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$226.48M | at low | |
| 3Y | -$226.48M | at low | |
| 5Y | -$226.48M | at low | |
| All | -$226.48M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ABCL?
As of today, ABCL TTM EBITDA is -$226.48M
What is ABCL TTM EBITDA most recent change?
ABCL TTM EBITDA was down -6.43% on September 30, 2025
What is 1-year change in ABCL TTM EBITDA?
ABCL TTM EBITDA is down -4.92% year-over-year
How far is ABCL TTM EBITDA from its all-time high?
ABCL TTM EBITDA is currently -150.87% below its historical high of $445.22M set on September 30, 2022
How does ABCL TTM EBITDA rank versus sector peers?
ABCL TTM EBITDA is higher than 5.79% of companies in Healthcare sector
When is ABCL next earnings release?
The next earnings release for ABCL is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ABCL Official Website www.abcellera.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1703057/000170305725000025/0001703057-25-000025-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1703057/000162828025008689/0001628280-25-008689-index.htm
- ABCL Profile on Yahoo Finance finance.yahoo.com/quote/ABCL
- ABCL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abcl